Clinique Ovo Joins with The Fertility Partners Inc
Significant Platform Extension for Healthcare New Venture
TORONTO, Aug. 5, 2020 /CNW/ - The Fertility Partners ("TFP") announced today it has joined with Montreal-based Clinique ovo, significantly expanding the foundation for a Canada-wide network of fertility clinics.
The Fertility Partners works with world class fertility clinics, providing access to shared medical, strategic and operational best practices, promoting research and development activities and offering extensive back-office support. Its goal is to foster global best clinical outcomes, an international reputation for excellence, and exceptional patient and employee experiences. The TFP partner model empowers physicians and their teams to focus on doing what they do best- provide the highest quality fertility medicine and services.
Says TFP's Founder, CEO & Executive Chairman Dr. Andrew Meikle, "we are honoured to partner with clinique ovo. As a leader in the field of Reproductive Medicine in Quebec with six locations, clinique ovo's reputation for high quality patient care is outstanding and as a result, it has become one of the most respected fertility research clinics in the country. We admire their patient-centered excellence, and believe clinique ovo will substantially strengthen our platform for future growth." TFP Chief Medical Officer Dr. Al Yuzpe says "this partnership reinforces our mutual commitment to high-quality healthcare. We share a common mission, to expand access to fertility treatment in Quebec, allocate more resources toward research and development, and provide even more comprehensive care programs that deliver an optimal patient experience."
The Fertility Partners prides itself on fostering a culture that is patient focused, collaborative, inclusive and transparent. clinique ovo will retain a high level of independence and complete clinical autonomy, while benefitting from the range of support services its new parent company can offer.
"We are delighted to join forces with The Fertility Partners to create long-term benefits for both employees and patients, and to grow our leading position in fertility, prenatal, and medical laboratory", says Dr. Francois Bissonnette, Medical Director of clinique ovo. "We see a real opportunity in being able to share best practices to improve clinical outcomes and to collaborate on R&D activities with other leading fertility clinics, for our patients."
About The Fertility Partners: The Fertility Partners is a new venture creating a network of respected fertility clinics across North America. The company aims to be a world class business partner of choice for leading IVF and prenatal practitioners with the goal of achieving global best clinical outcomes, operational excellence and exceptional patient experiences. TFP provides partner clinics with back office support and a collaborative, synergistic medical-scientific, professional and business environment. For more information, please visit www.thefertilitypartners.com.
About clinique ovo: Since its inception in 2003, clinique ovo has offered its services to more than 90,000 patients in fertility, prenatal screening, medical laboratory, preservation of umbilical cord blood, and general women's health through its main Montreal office as well as six satellite clinics in the greater Montreal area, Quebec City and Mont-Laurier. For more information, please visit www.cliniqueovo.com.
Dancing To The Darkest Light Aims To Inspire Others Who Are Navigating Challenging Times
Los Angeles, CA, August 5, 2020— Soheila Adelipour hopes you never look at life the same way after reading her memoir of survival, Dancing to the Darkest Light. Her story begins in Iran, where her family, desperate to escape the Islamic revolution, fled to New York. Her family found solid footing in the Big Apple, living the epitome of the American dream, until one day, all they had were nightmares. In a relatively short period of time, Adelipour lost a son and two siblings. Her book offers a riveting account of her healing process, and through her example of extraordinary resilience, she hopes to inspire others who are facing tragedy and heartbreak.
Chronicling their experiences in Dancing to the Darkest Light, Adelipour recounts how her only brother became a neurosurgeon while others followed different paths. But their successful relocation and the joy they felt over each triumph was soon shattered when Adelipour's second son, Stefan, was killed in a dorm room fire before his scheduled graduation from Boston University.
Adelipour channeled her grief into the foundation she established in his name. Soon after, her older sister had to undergo five brain surgeries that left her blind and deaf before ultimately claiming her life. The same week, their only brother who was supervising her care was diagnosed with leukemia. Adelipour gave him her bone marrow and 60 percent of her liver when his liver stopped functioning. Doctors ultimately announced he was cancer-free with a perfectly functioning liver, but the week he was to come home, he died from pneumonia.
How one perseveres under the weight of all this loss is at the core of Dancing to the Darkest Light. “When life plays different music, we have to be fluid and dance to the new tune,” Adelipour said.
Adelipour received her bachelor's degree in business and her master's degree in Art Gallery Management while her first two children were in diapers. She was involved with the World of Arts and Antiques in New York City and followed that by operating high-end gift stores.
Estée Lauder Introduces New Advanced Night Repair Synchronized Multi-Recovery Complex
Estée Lauder revolutionizes the brand's #1 nighttime serum with new fast repair and youth-generating power
TORONTO, Aug. 5, 2020 /CNW/ - Backed by an unprecedented new discovery in the scientific field of Epigenetics, Estée Lauder introduces the revolutionary new Advanced Night Repair Synchronized Multi-Recovery Complex. With breakthrough new ChronoluxTM Power Signal Technology, new Advanced Night Repair now supports skin's natural repair more effectively than ever, and for the first time, helps skin increase its natural renewal of fresh new cells and production of collagen for firmer skin. Advanced Night Repair absorbs fast as it works to reduce the look of multiple signs of aging and helps protect skin from the environmental assaults of modern life. After one dropper skin looks radiant and plumped with hydration, after just three weeks lines appear reduced, and after one bottle skin feels firmer and looks healthy, younger, with new bounce and vitality.1
Breakthrough Epigenetics Discovery
In the scientific field of epigenetics, it has been shown that only around 25% of aging is predetermined by your genes. The remaining 75% of the aging process is believed to be influenced by environmental and lifestyle factors. In the early 2000s a powerful new class of epigenetic micro signaling molecules were discovered. These small molecules are present throughout the body, and quickly communicate responses to external changes.
For the past seven years, Estée Lauder scientists researched over 80 micro signaling molecules found in skin cells to better understand their role in skin aging. In a breakthrough discovery, Estée Lauder identified a specific micro signaling molecule that is essential to skin's natural repair and promotes multiple vital anti-aging pathways. Significantly, this micro signaling molecule helps skin increase its natural renewal of fresh, new cells and boosts its natural collagen production.2 Estée Lauder's in vitro research also shows that the level of this micro signaling molecule in skin cells declines as part of the aging process.
New ChronoluxTM Power Signal Technology
Inspired by the science of epigenetics, this exclusive technology, including a new patent-pending micro signaling molecule activator, is powered by a proprietary blend of yeast extract, a peptide, and plant-derived ingredients to help maximize skin's natural repair fast and boost skin's natural youth-generating power.
Helps rapidly ignite a dynamic, connected repair network to help promote skin's natural repair processes.
Helps support the natural synchronization of skin's renewal processes so skin repairs at exactly the right time – at night, and maximizes skin's natural night and day rhythm of repair and protection.
Supports skin cells' natural purification process to help address cellular damage.
Helps skin increase its natural skin cell renewal and production of fresh new skin cells by 43%.3
Helps skin increase its natural production of collagen.4
Fast Repair and Youth-Generating Power
Clinical Results1:
ONE DROPPER
Skin is radiant and plumped with 72-hour hydration
All-day 8-hour antioxidant protection
Skin barrier is strengthened
THREE WEEKS
Lines appear reduced
ONE BOTTLE (50ml)
Skin feels firmer
Skin looks healthy, has a new bounce and vitality
OVER TIME
Pores appear diminished
Skin looks more even-toned
Sensory Results5:
AFTER ONE DROPPER
90% said their skin felt softer and smoother
90% said it absorbed into skin quickly
AFTER THREE WEEKS
91% said skin looked more rested
88% said skin looked plumped and more youthful
85% said their lines appeared diminished
AFTER ONE BOTTLE
91% said skin was left with a healthy glow
89% said skin felt firmer and skin's elasticity improved
New Sleek Glass Bottle The apothecary inspired "little brown bottle" has been reimagined, and transformed into stunningly crafted premium, recyclable glass, with a sleek silhouette and enhanced translucency gradient for a more 'lit from within" glow.
Usage: Apply on clean skin before moisturizer, AM and PM.
Appropriate for all skin types and all ethnicities. Dermatologist tested. Ophthalmologist tested, Non-acnegenic.
Free of oil, phthalates, sulfites and sulfates, parabens, mineral oil
Patented until 2033.
Tested on all ethnicities.
Available at all Estee Lauder counters from August 6th 2020: Pricing: 30ml - $95.00 and 50ml - $130.00
___________________________
1 Clinical testing of Advanced Night Repair Synchronized Multi-Recovery Complex.
2 In vitro testing.
3 In vitro testing of a key active in ChronoluxTM Power Signal Technology on 62-year old skin cells over 7 days.
4 In vitro testing of ChronoluxTM Power Signal Technology actives after 72 hours.
5 Consumer testing on 543 women after using Advanced Night Repair Synchronized Multi-Recovery Complex for 4 weeks.
SOURCE Estee Lauder Cosmetics Ltd.
COVID-19 Shines A Bright Light On Disparities In Health Care Among People Of Color
New York, NY, August 5, 2020 ̶“During the coronavirus pandemic, people should guard their eyes with glasses or face shields to protect their eyes from virus infection,"said Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York. People also need to know, even though there are many concerns about COVID-19, common-sense precautions can significantly reduce the risk of infection, he says, adding: “Wash hands frequently, follow good contact lens hygiene and avoid rubbing or touching our mouth, nose, and especially our eyes.'' Dr. Laroche is also affiliated with the New York Eye and Ear Infirmary of Mount Sinai, Island Eye Surgical Center, and New York University.
The COVID-19 pandemic has also changed the way people visit their doctors. For patients over 60, Dr. Laroche advises it's better to stay home and do telehealth over the phone or video consultation until the pandemic flattens. He also encourages people to wear face masks on visits and maintain social distancing, even if they are in a health clinic. “Eyesight or human vision is one of the most important senses. As much as 80% of what we feel comes through our sense of sight. By protecting the eyes, people will reduce the chance of blindness and vision loss while also staying on top of any developing eye diseases, such as glaucoma and cataracts. A healthy brain function requires a healthy vision. The brain is our most essential organ, and It allows us to control other organs. Normal and healthy vision contributes to improved learning and comprehension for a better quality of life,” says Dr. Laroche.
Dr. Laroche says there is another critical issue that COVID-19 has brought to the forefront and that is the issue of health care disparities among Black and Brown people. “Nationally, African American deaths from COVID-19 are nearly two times greater than would be expected based on their share of the population. In four states, the rate is three or more times greater. In forty-two states, plus Washington, D.C., Hispanics make up a greater share of confirmed cases than their share of the population. In eight states it’s more than four times greater,” he says, adding: “In stark contrast, White deaths from COVID-19 are lower than their share of the population in thirty-seven states.”
Dr. Laroche says there are several things that can be done to not only address but to help combat this issue:
1. Increase the number of Black and Afro-Latino physicians worldwide.
2. Implement universal healthcare.
3. Increase wealth and education which produces better health.
4. Provide a living income stipend for poor people to access food and reduce malnutrition.
5. Eliminate racism to reduce stress.
6. Identify white supremist organizations as terrorist groups.
7. Recommend all corporations have people of color in the top management and leadership positions.
8. Eliminate sole reliance on standardized testing as the criteria to be used at entry to magnet schools.
9. Provide more funding to reduce homelessness and for mental health.
10.The government should also require medical school, research and hospital funding to diversify and benefit people of color.
About Dr. Daniel Laroche:
Dr. Laroche is an exceptional glaucoma specialist in New York. He studied and received his bachelor's degree from New York University and a medical doctorate with honors in research from Weil Cornell University Medical College. He underwent a medical internship at Montefiore Hospital and finished his Ophthalmology residency at Howard University Hospital in Washington D.C., where he was the chief resident in his third year. He later completed his glaucoma fellowship at New York Eye and Ear.
For more information about Dr. Laroche, please call 212-663-0473 or visit: www.advancedeyecareny.com.
###
Empagliflozin meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in Phase III trial in adults with and without diabetes
Empagliflozin significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction
Treatment of heart failure is an important unmet need with over half of those diagnosed dying within five years1
The EMPEROR-Reduced trial included 32 study sites across Canada
BURLINGTON, ON and TORONTO, Aug. 5, 2020 /CNW/ - Positive top-line results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, were announced by Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY). EMPEROR-Reduced met its primary endpoint, demonstrating superiority with empagliflozin (10 mg) compared to placebo in reducing the risk for the composite of cardiovascular death or hospitalization due to heart failure, when added to standard of care. Overall, the safety profile was similar to the known safety profile of empagliflozin.
"Heart failure is on the rise and is a major cause of death, disability and cost to Canadians. New therapies to treat heart failure are urgently required," said Dr. Subodh Verma, a Professor and Cardiac Surgeon at the University of Toronto at St Michael's Hospital, who served as the Canadian lead investigator on the trial and as a member of the Scientific Excellence Committee for the EMPEROR Program. "The results of the EMPEROR-Reduced trial demonstrate that empagliflozin is poised to represent a new standard of care for heart failure, and can add quite considerably to what can be achieved with the current established treatments."
An estimated 600,000 Canadians are living with heart failure, and the risk of death in people with heart failure rises with each hospital admission.2,3 Heart failure with reduced ejection fraction occurs when the heart muscle does not contract effectively, and less blood is pumped out to the body compared to a normally functioning heart.4 Symptoms associated with heart failure, such as breathlessness and fatigue, can impact quality of life.2
"One in five people can expect to develop heart failure in their lifetime, so it is very encouraging to see these positive results from the EMPEROR-Reduced trial demonstrating that empagliflozin improves heart failure outcomes," said Waheed Jamal, M.D., Corporate Vice President and Head of CardioMetabolic Medicine, Boehringer Ingelheim. "We are excited to share the full results and are working tirelessly to explore how empagliflozin can improve the lives of people living with heart failure."
Full results from the EMPEROR-Reduced trial will be presented in a hot line session at the European Society of Cardiology (ESC) Congress 2020 on August 29, and regulatory submissions are planned in 2020.
Additionally, a second study, the EMPEROR-Preserved trial is exploring the effect of empagliflozin on cardiovascular death or hospitalization in adults with heart failure with preserved ejection fraction – an area with no approved treatment options.5,6EMPEROR-Preserved results are expected in 2021.
The EMPEROR trials are part of the EMPOWER clinical program, one of the broadest and most comprehensive of any SGLT2 inhibitor, exploring the impact of empagliflozin on the lives of people across the spectrum of cardio-renal-metabolic conditions.
"These results build upon the already established cardiovascular benefits of empagliflozin in adults living with type 2 diabetes and cardiovascular disease," said Jeff Emmick, M.D., Ph.D., Vice President, Product Development, Lilly. "Metabolic conditions that affect the heart and kidneys can lead to serious consequences, including hospitalizations and death. Through our EMPOWER clinical program, we are committed to advancing knowledge about these devastating clinical outcomes. We look forward to seeing how empagliflozin can help adults around the world living with these conditions."
About the EMPEROR Heart Failure Studies6,7 The EMPEROR (EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure) chronic heart failure studies are two Phase III, randomized, double-blind trials investigating once-daily empagliflozin compared with placebo in adults with chronic heart failure with preserved or reduced ejection fraction*, both with and without diabetes, who are receiving current standard of care:
EMPEROR-Reduced [NCT03057977]: will investigate the safety and efficacy of empagliflozin in patients with chronic heart failure with reduced ejection fraction (HFrEF)
Primary endpoint: time to first event of adjudicated cardiovascular death or adjudicated hospitalization for heart failure
Number of patients: 3,730
Completion: 2020
EMPEROR-Preserved[NCT03057951]: will investigate the safety and efficacy of empagliflozin in patients with chronic heart failure with preserved ejection fraction (HFpEF).
Primary endpoint: time to first event of adjudicated cardiovascular death or adjudicated hospitalization for heart failure [Time Frame: up to 38 months]
Anticipated number of patients: approx. 5,990
Estimated completion: 2021
*Ejection fraction is a measurement of the percentage of blood the left ventricle pumps out with each contraction. When the heart relaxes, the ventricle refills with blood. HFrEF occurs when the heart muscle does not contract effectively, and less blood is pumped out to the body compared with a normally functioning heart. HFpEF occurs when the heart muscle contracts normally but the ventricle does not fill with enough blood, so less blood can enter the heart compared with a normally functioning heart.
About the EMPOWER program The Alliance has developed the EMPOWER program to explore the impact of empagliflozin on major clinical cardiovascular and renal outcomes in a spectrum of cardio-renal-metabolic conditions. Cardio-renal-metabolic conditions are the leading cause of mortality worldwide and account for up to 20 million deaths annually.8 Through the EMPOWER program, Boehringer Ingelheim and Lilly are working to advance knowledge of these interconnected systems and create care which offers integrated, multi-organ benefits. Comprised of nine clinical trials and a real-world evidence study, EMPOWER reinforces the long-term commitment of the Alliance to improve outcomes for people living with cardio-renal-metabolic conditions. With more than 27,000 adults enrolled worldwide in clinical trials, it is one of the broadest and most comprehensive clinical programs for an SGLT2 inhibitor to date.
About Heart Failure Heart failure is a progressive, debilitating and potentially fatal condition that occurs when the heart cannot supply adequate circulation to meet the body's demands for oxygenated blood or to do so requires increased blood volume leading to fluid accumulation (congestion) in the lungs and peripheral tissues.9 An estimated 600,000 Canadians are living with heart failure.2 Worldwide 60 million people are affected and the prevalence is expected to increase as the population ages.10 Heart failure is highly prevalent in people with diabetes11 however, approximately half of all people with heart failure do not have diabetes.10,12
The empagliflozin heart failure program was initiated based on data from the EMPA-REG OUTCOME® trial, which assessed the effect of empagliflozin added to standard of care compared with placebo added to standard of care.13
About Cardio-Renal-Metabolic Conditions Boehringer Ingelheim and Lilly are driven to transform care for people with cardio-renal-metabolic conditions, a group of interconnected disorders that affect more than one billion worldwide and are a leading cause of death.8
The cardiovascular, renal and metabolic systems are interconnected, and share many of the same risk factors and pathological pathways along the disease continuum. Dysfunction in one system may accelerate the onset of others, resulting in progression of interconnected diseases such as type 2 diabetes, cardiovascular disease, heart failure, and kidney disease, which in turn leads to an increased risk of cardiovascular death. Conversely, improving the health of one system can lead to positive effects throughout the others.14,15
Through our research and treatments, our goal is to support people's health, restoring the balance between the interconnected cardio-renal-metabolic systems and reducing their risk of serious complications. As part of our commitment to those whose health is jeopardized by cardio-renal-metabolic conditions, we will continue embracing a multidisciplinary approach towards care and focusing our resources on filling treatment gaps.
About Empagliflozin Empagliflozin is an oral, once daily, highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor and the first type 2 diabetes medicine to include cardiovascular death risk reduction data in its label in several countries.16,17
Inhibition of SGLT2 with empagliflozin in people with type 2 diabetes and high blood sugar levels prevents sugar being re-absorbed by the kidneys, leading to the excretion of excess sugar in the urine. In addition, initiation of empagliflozin also prevents salt being re-absorbed, leading to increased excretion of salt from the body and reducing the fluid load of the body's blood vessel system (i.e. intravascular volume). Empagliflozin induces changes to the sugar, salt and water metabolism in the body that may contribute to the reductions in cardiovascular death observed in the EMPA-REG OUTCOME trial.18
About Boehringer Ingelheim and Eli Lilly and Company In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centres on three pipeline compounds representing several of the largest treatment classes. This Alliance leverages the strengths of two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of people with diabetes and stand together to focus on patient needs. For more information about the Alliance visit www.boehringer-ingelheim.ca or www.lilly.ca.
About Boehringer Ingelheim (Canada) Ltd. Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.
As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Our significant investment of almost 3.5 billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.
About Eli Lilly Canada Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people's needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto, which eventually produced the world's first commercially-available insulin. Our work focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at www.lilly.ca.
For our perspective on issues in healthcare and innovation, follow us on twitter @LillyPadCA.
References
_________________________________
1
Ponikowski P, Anker SD, AlHabib KF. Heart Failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4–25.
Solomon S, Dobson J, Pocock S, et al. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients with Chronic Heart Failure. Circulation. 2007;116(13):1482–7.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016; 388(10053):1459–544.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
11
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;128(16):e240–e327.
12
Suskin N, McKelvie RS, Burns RJ, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 2000;21:1368–75.
13
Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med.2015;373:2117–28.
14
Ronco, P. McCullough, S. D. Anker et al., "Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative," European Heart Journal, vol. 31, no. 6, pp. 703–711, 2010.
15
C. Lazzeri, S. Valente, R. Tarquini, and G. F. Gensini, "Cardiorenal syndrome caused by heart failure with preserved ejection fraction," International Journal of Nephrology, vol. 2011, Article ID 634903, 7 pages, 2011.
European Summary of Product Characteristics Jardiance®, approved May 2018. Data on file.
18
Vallon V and Thompson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia. 2017;60(2):215–25.
SOURCE Boehringer Ingelheim (Canada) Ltd.
Anti-Black racism awareness and response linked to Canadians' mental health
Morneau Shepell's Mental Health Index™ shows 10-point decline from the pre-pandemic benchmark of 75
TORONTO, Aug. 5, 2020 /CNW/ - Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its monthly Mental Health Index™ report, showing a consistent negative mental health score in Canada for the fourth consecutive month. The findings show that the ongoing impact of COVID-19, coupled with the increased awareness and societal response to anti-Black racism, continue to affect the mental health of Canadians.
The Mental Health Index™ score is -10. The score measures the improvement or decline in mental health from the pre-2020 benchmark of 75. This month's overall score is one point higher than the score last month. The Mental Health Index™ also tracks sub-scores against the benchmark, measuring the risk of depression (-12.4), anxiety (-12.3), optimism (-11.4), work productivity (-11.1) and isolation (-11.0). While the sub-scores remain low, all areas have improved when compared to each previous month.
"July marks the fifth month since COVID-19 was declared a global pandemic and Canadians began experiencing a collective mental health crisis," said Stephen Liptrap, president and chief executive officer. "While many businesses, amenities and public spaces have reopened and a slight sense of normalcy has started to emerge across the country, our Mental Health Index™ shows that improving mental wellbeing takes time. In addition to restarting the Canadian economy, it's critical that organizations and governments continue to be vigilant in providing mental health support."
Strong correlation between Black Canadians' mental health and anti-Black racism awareness
The killing of Black American, George Floyd, initiated an international anti-Black racism awareness movement. The Mental Health Index™ found that overall, nearly 70 per cent of individuals believe that racism is a problem in Canada. Twenty (20) per cent believe that racism is a problem in their workplace. When comparing results by race, 62 per cent of individuals who identified as Black agreed or strongly agreed that racism is a problem in their workforce, compared to 14 per cent of individuals who identified as White.
Respondents who identified as Black showed a 1.8-point decrease in their Mental Health Index™ score between May and June, and a 0.9-point increase to -17.7 in July. Those who identified as White showed consistent improvement without the same decline in June, with a 1.2-point increase between May and June and a 1.8-point increase in July.
These results demonstrate that the most intense period of awareness and response to anti-Black racism corresponded with a decline in mental health scores among Black Canadians. As the conversation on systemic racism continues the mental health score of Black Canadians is showing improvement. Looking forward, 40 per cent of all respondents feel that systemic racism is likely to decrease in Canada as a result of heightened anti-Black racism awareness, while 33 per cent are unsure and 27 per cent feel that systemic racism is unlikely to decrease.
"Systemic racism is not a new issue in Canada nor elsewhere, yet many Canadians are just now opening their eyes to the issue for the first time," said Paula Allen, senior vice president of research, analytics and innovation. "The dialogue that has started recently is critical for social change as well as the wellbeing of individuals and organizations. The experience of racism is traumatic and the ability to safely speak about it and problem solve is critical, and has been supported by many organizations. The benefit of that is starting and needs to continue."
Majority of Canadians feel COVID-19 has not impacted personal relationships
The social effects of COVID-19 have been felt from coast-to-coast, with prolonged physical distancing and isolation measures leading Canadians to crave human interaction. Morneau Shepell's Mental Health Index™ found that with multiple restrictions, 30 per cent have experienced some change in their personal relationships since January 2020. Sixteen (16) per cent of respondents feel that there has been an improvement in their personal relationships, while 14 per cent feel their personal relationships have become more strained. In the workplace, one quarter (25 per cent) feel there has been a change in their relationships. Eleven (11) per cent report an improvement and 14 per cent indicate increased strain in their workplace relationships. Those with no change in either personal relationships or workplace relationships have the highest Mental Health Index™ scores (-7.1 and -7.5 respectively), followed by positive change (-10.3 for improved personal relationship and -12.5 for improved workplace relationship). Those with a negative change in personal or workplace relationships have the lowest mental health scores (-27.7 for more strained personal relationship and -23.9 for more strained workplace relationships). The data demonstrates that the importance of stable relationships to mental health.
"Both personal and workplace relationships are important to wellbeing," said Allen. "In the workplace especially, relationships with coworkers are critical to feeling valued, recognized and having a sense of belonging. With many Canadians working and communicating entirely remotely, supporting workplace culture is more important than ever to ensure employee mental health remains a top priority."
About the Mental Health Index™
The monthly survey by Morneau Shepell was conducted through an online survey in English and French from June 22 to June 30, 2020, with 3,000 respondents in Canada. All respondents reside in Canada and were employed within the last six months. The data has been statistically weighted to ensure the regional and gender composition of the sample reflect this population. The margins of error for the survey are +/- 3.2 per cent, valid 19 times out of 20. The Mental Health Index™ is published monthly, beginning April 2020, and compares against benchmark data collected in 2017, 2018 and 2019. The full Canadian report can be found at: https://www.morneaushepell.com/permafiles/92896/mental-health-index-report-canada-july-2020.pdf
About Morneau Shepell
Morneau Shepell is a leading provider of technology-enabled HR services that deliver an integrated approach to employee wellbeing through our cloud-based platform. Our focus is providing world-class solutions to our clients to support the mental, physical, social and financial wellbeing of their people. By improving lives, we improve business. Our approach spans services in employee and family assistance, health and wellness, recognition, pension and benefits administration, retirement consulting, actuarial and investment services. Morneau Shepell employs approximately 6,000 employees who work with some 24,000 client organizations that use our services in 162 countries. Morneau Shepell is a publicly traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit morneaushepell.com.
SOURCE Morneau Shepell Inc.
Thermo Fisher Scientific Launches Exclusive Website for its Chemical Business Offerings in India- Equipped with customized search, customers can explore on-demand seminars and technical literature
05 August 2020Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new website for its chemicals business offerings. This website will serve as a dedicated platform towards an extensive range of Laboratory and Production chemicals. The new website will bring all major chemical brands from Thermo Fisher Scientific including Alfa Aesar, Acros Organics, Fisher Chemicals, Qualigens, Fisher Bioregaents and Maybridge under one umbrella. Qualigens, the locally manufactured brand in India, will have its first online presence through this website. This will enable customers to explore the chemicals portfolio and have a consistent digital experience. Thermo Fisher invites customers from various segments including educational institutions, research and development, pharmaceuticals, diagnostics, food & beverage and environmental sector, to get acquainted with the capabilities that the new website will offer. The website is equipped with customized chemical search capabilities like structure search and element search and options to view availability and pricing for specific brands. The website has also been designed to cater to distinct purchase lifecycles of buyers and customers, who can also explore on-demand seminars and technical literature. "At Thermo Fisher, we offer a robust portfolio of chemicals that are used from bench to production spanning across industries. I am delighted that this website is getting launched at a time when our customers need us more than ever digitally. Customers can now access our chemical brands and experience our entire portfolio offering, all in one place.With this new platform we are now one step ahead in serving our customers better.” said Amit Chopra, managing director, India and Middle East, Thermo Fisher Scientific “The global coronavirus outbreak is a powerful reminder of the importance of our mission- to enable our customers to make the world healthier, cleaner and safer. We are profoundly aware of our obligation towards our customers as essential partners and these initiatives reinforce our commitment to serve our customers”, said Amit. The website is exclusive to India. Login to the new website to explore our solutions at https://www.thermofisher.in/chemicals/en/home.htmlAbout Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.For more information, please visit www.thermofisher.com.
A Peaceful Oasis Designed to Help You Reset
Four Local Women Pool Talents to Launch ‘ReSet Lounge’ in Chagrin Falls
Chagrin Falls, Ohio (Issued August 2020) -- During 2019, four women – mothers to a total of 11 – decided there was something missing in their otherwise idyllic Village of Chagrin Falls, a suburb of Cleveland, Ohio.
“We’re fortunate to live in such a peaceful place,” says co-founder Beth Johnson, “but we realized that families everywhere, at some point in their lives, experience issues related to marriage, separation, divorce, ADHD, anxiety, depression, suicidal ideation, addiction, chronic illness, autism, aging and loss of loved ones, strokes, heart attacks, cancer, dementia and more. And the strain of those is compounded by the 24/7 news cycle, in addition to the pandemic.” (Photo, left to right: Beth Rowell, Vicky Childres, Leigh Kruszenski, Beth Johnson)
She adds, “There was no oasis where people of all ages could go to take a breath, to catch up, to reset from the many difficulties life brings. Managing the stress and anxiety of today’s world, and the toll it can take on your body and mind, is a daunting task. Life can be hard. We wanted to create a space that made it a little easier.” And that was the birth of the ReSet Lounge, a 3,600 square foot health and wellness studio at 530 East Washington St., Chagrin Falls.
In addition to their shared philosophy about healthy living and a strong family life, each founder brought special skills and experience to the new enterprise: Vicky Childres was a fashion director for Saks Fifth Avenue, owned a home décor shop, and is currently CEO of CGL Real Estate Holdings (and lead singer of Soulshine.) Beth Johnson is a long-time business executive and technology consultant. Leigh Kruszenski is a Certified Functional Medicine Health Coach, passionate about empowering people to be stewards of their own health. And Beth Rowell is a Certified Personal Trainer with 20+ years of fitness industry experience.
Co-founder Kruszenski says “ReSet’s services target inflammation, pain, toxins, stress and anxiety while promoting circulation, strength, happiness and sounder sleep.” These unique services include cryotherapy, infrared saunas, salt therapy, massage and compression chairs, whole body vibration, zero gravity positioning, vitamin IV infusions, supplements, and NuCalmÒ neuroscience therapy. ReSet’s trainers and coaches offer personal training, health coaching and advice on vitamin supplements to boost one’s immune function.
One of Reset Lounge’s most popular offerings is the award-winning, FDA-approved NuCalmÒ therapy, clinically proven to combat stress and improve sleep patterns, to ‘reset’ important systems in your body. Without drugs or side-effects, NuCalm calms the body by counteracting adrenaline, stimulating microcurrents, calming the pace of brain waves, and blocking visual stimuli to encourage relaxation. Research shows that a 20-minute session may provide the equivalent of up to two hours of deep, restorative sleep.
The NuCalmÒ system involves a biosignal processing disc placed on the wrist, noise-cancelling headphones, the NuCalm App providing neuroacoustic software, and an eye mask, while resting in a zero-gravity recliner.
One 16-year-old NuCalmÒ user said, “I felt like I was back in the womb -- so safe.” The mother of an 8 year old with ADD cried while watching her daughter’s session, and exclaimed, “I never saw her so still and relaxed before.” A 21-year-old who struggled with insomnia since age 11 tried several traditional cures until she found NuCalmÒ at ReSet: “My body and mind were so relaxed after my first session yet I felt completely energized - I decided I needed to use NuCalm daily. I bought my own unit and now my overall sleep quality is much more restful, and the anxiety I had for years is finally relieved.”
Adding NuCalm to the vitamin IV infusions allows a client to ‘stack’ their recovery; as NuCalm puts the body in a parasympathetic recovery state and allows for a better absorption rate while stress is reduced.
When asked about the ReSet Lounge concept, Johnson said she, “wanted to make services available that I wish I had when my children were younger. I realized that in my middle-aged life, I was the perfect client.” Co-founder Childres said, “I wanted to create a space where one could unplug and escape the noise of our 24/7 news cycle world -- a space where the mind and the body could take a deep exhale, a space where one could solely focus on a mind and body reset.”
Kruszenski adds, “Having gone through my own health journey and realizing that lifestyle changes can have such a profound impact on overall wellness, I wanted to create a space with resources and services to help people find the tools to make them feel better.”
And co-founder Beth Rowell said, “After going through profound struggles with one of my children, and knowing how a place like ReSet would have been a refuge for both of us during that difficult time, I knew I wanted to be part of creating a place where people could come to recover physically and mentally from the chaos of life… There are many benefits to meditation, but it can be challenging. NuCalmÒ does all the heavy lifting for you and coaxes your body and mind to a deep, restorative state.”
Rowell continued, “Once you experience NuCalmÒ, you’re a convert. Clients travel 35 miles or more to experience our services. Some come from as far as Akron and Youngstown. Another reason for our success: We offer a specialized Midwest combo of wellness services under one roof.”
The patented NuCalmÒ technology has won awards at the Consumer Electronics Show, was featured on NBC’s TodayShow, and has been used for years by professional athletes and elite military operators to achieve accelerated recovery without drugs.
Sessions at the ReSet Lounge range from 20 – 60 minutes for all services and can be reserved online. Prices range from $20 to $60 depending on the service and session length. For more info or to book an appointment, download the ReSet Lounge App or contact : 440-600-2659 / info@resetlounge.com - By Stan Hurwitz / stanhurwitz@gmail.com
Olive Fertility Centre Joins With The Fertility Partners Inc
Significant Platform Extension for Healthcare New Venture
TORONTO, Aug. 5, 2020 /CNW/ - The Fertility Partners ("TFP") announced today it has joined with Vancouver-based Olive Fertility Centre, significantly expanding the foundation for a Canada-wide network of fertility clinics.
The Fertility Partners works with world class fertility clinics, providing access to shared medical, strategic and operational best practices, promoting research and development activities and offering extensive back-office support. Its goal is to foster global best clinical outcomes, an international reputation for excellence, and exceptional patient and employee experiences. The TFP partner model empowers physicians and their teams to focus on doing what they do best- provide the highest quality fertility medicine and services.
Says TFP's Founder, CEO & Executive Chairman Dr. Andrew Meikle, "we are very excited to partner with Olive Fertility Centre, voted Best Fertility Clinic in Vancouver for each of the past four years. It is recognized across Canada for its quality of patient care and delivers some of the highest pregnancy rates in the country. Olive also won the prestigious Globe & Mail 2020 Employee Recommended Workplace Award, and this commitment to helping its people thrive will enrich and provide a model for us all." TFP Chief Medical Officer Dr. Al Yuzpe says, "bringing The Olive Fertility Centre into our platform will allow our member clinics to deliver enhanced patient care via shared clinical and scientific innovations that will further improve our patients' experience and treatment outcomes."
The Fertility Partners prides itself on fostering a culture that is patient focused, collaborative, inclusive and transparent. Olive Fertility Centre will retain a high level of independence and complete clinical autonomy, while benefitting from the range of support services its new parent company can offer.
Dr. Jason Hitkari, Medical Director of Olive Fertility Centre states, "we are absolutely thrilled to be partnering with The Fertility Partners. The idea of working collaboratively with other fertility clinics within the partnership to optimize clinical outcomes, pursue evidence-based research, and move innovation forward is very exciting to all of us here at Olive Fertility Centre. Our vision of providing exceptional patient-centred care along with exceptionally good patient outcomes aligns perfectly with what The Fertility Partners is trying to achieve for patients across the country."
About The Fertility Partners: The Fertility Partners is a new venture creating a network of respected fertility clinics across North America. The company aims to be a world class business partner of choice for leading IVF and prenatal practitioners with the goal of achieving global best clinical outcomes, operational excellence and exceptional patient experiences. TFP provides partner clinics with back office support and a collaborative, synergistic medical-scientific, professional and business environment. For more information, please visit www.thefertilitypartners.com.
About Olive Fertility Centre: With offices in Vancouver, Richmond and Surrey BC, Olive Fertility Centre offers a state-of-the-art laboratory facility, personalized care, and advanced fertility treatments such as IVF, Preimplantation Genetic Testing (PGT-A) and egg freezing. Olive is committed to providing fertility treatments that are patient centred, safe, effective, efficient, timely, and equitable. The Centre aspires to provide the highest quality services to patients, continually improve standards of care, and be recognized as the best fertility clinic in Canada. For more information, please visit www.olivefertility.com.
SOURCE The Fertility Partners
Samsung Unveils Five New Galaxy Devices To Empower Your Work and Play
Galaxy Note20 5G and Galaxy Note20 Ultra 5G are productivity powerhouses, seamlessly connecting with the Galaxy ecosystem to help you live every moment to the fullest.
MISSISSAUGA, ON, Aug. 5, 2020 /CNW/ - Today, Samsung Electronics Canada participated in the first-ever Galaxy Unpacked virtual event to introduce a new suite of powerful devices, livestreamed from Korea. Five devices were revealed during the event, that seamlessly integrate to empower consumers navigating a rapidly changing world: Galaxy Note20 5G and Galaxy Note20 Ultra 5G, the most powerful Note line yet; Galaxy Tab S7 and Galaxy Tab S7+, versatile tablets for productivity and creativity; Galaxy Watch3, a premium smartwatch packed with advanced fitness features; Galaxy Buds Live, stylish and ergonomic earbuds with amazing sound quality; and Galaxy Z Fold2, the next generation foldable smartphone with enhanced refinements1.
"Never before have we relied on technology like we are today. It's how we are staying connected as we navigate the extraordinary challenges faced around the world," said Dr. TM Roh, President and Head of Mobile Communications Business, Samsung Electronics. "Technology must make life easier, not more complex. That's why we have introduced five new power devices. Alone, these devices are powerful tools to help you maximize work and play. Together, as part of the Galaxy ecosystem, they work seamlessly so you can spend your time focused on what matters most."
Galaxy Note20 5G and Note20 Ultra 5G, the Most Powerful Note Series Yet The Galaxy Note20 Series 5G smartphones are productivity powerhouses that work like a computer and let you game like a pro. The series features two innovative devices: Galaxy Note20 Ultra 5G, designed for Note fans who demand the ultimate in performance and productivity, and Galaxy Note20 5G, for broader Note users looking to maximize their time for work and play. Both are built for efficiency, so you can focus on staying connected with the people you love.
Power to Work Today, we need devices that are as flexible as we are, so we can work, play and connect how we want. Take your productivity to the next level with the Galaxy Note20 5G and Note20 Ultra 5G. The latest Galaxy Note series from Samsung helps transform the way you work—empowering you to do more, wherever life takes you. Now, on the Galaxy Note20 5G and Note20 Ultra 5G, the new S Pen and Samsung Notes features provide an even more powerful pen to paper experience2, and these features extend to the Galaxy Tab S7 and Tab S7+ for flexibility and convenience. Plus, a deeper relationship with long-standing Samsung partner, Microsoft, makes the Galaxy Note20 Series 5G and your Windows PC work together seamlessly.
An Advanced S Pen: A favourite among Note loyalists and multitaskers, the enhanced S Pen of the Galaxy Note20 Series 5G offers a superb writing experience so you can capture your ideas whenever inspiration strikes. Galaxy Note20 Series 5G has more lifelike precision than ever to give you true pen-to-paper accuracy and responsiveness3. With the five new Anywhere actions on the S Pen, touchless navigation of your device – like returning to the home screen or taking a screenshot – is as simple as a flick of the wrist.
Flexible and Intelligent Samsung Notes Experience: We need tools designed to let us work anytime, on any device. To help you capture, edit and share your ideas across your compatible phone, tablet or Windows 10 PC, Samsung Notes features auto-save and syncing capabilities, so you can pick up right where you left off as you move from device to device. Samsung Notes easily straightens quick handwritten thoughts into legible penmanship. Giving feedback on-the-go is also easy now that you can annotate and highlight PDFs in the Samsung Notes app. Record audio as you jot down ideas, and just tap a word in your notes to go to that moment in the recording. Keep it all organized with new, intuitive folder management that makes everything easier to find.
Work Smarter Across Devices: The Microsoft Your Phone app with Link to Windows4 integration now enables you to easily access your mobile apps directly from your Windows 10 PC without disrupting your flow. It's simple and convenient to send messages, manage notifications, sync photos, and make and receive calls all from your Windows 10 PC. Add your favourite mobile apps to your Taskbar or Start menu so you don't have to search your phone for favourite social media apps and Gallery. Later this year, you will have the ability to run multiple apps side by side on your Windows 10 PC. You can align your productivity ecosystems across your compatible devices by syncing Samsung Notes to Microsoft OneNote and Outlook, or sync your Reminders with Microsoft Outlook, To Do and Teams5 so your files are at your fingertips, no matter where your work takes you.
Power to Play Samsung is also bringing its Microsoft partnership to the entertainment side of Galaxy Note20 Series 5G, taking mobile play to the next level. Fully immerse yourself in the most powerful mobile gaming experience Samsung has ever engineered into a smartphone, so you can game like a pro from your couch, backyard, or around the house. The Galaxy Note20 5G and Note20 Ultra 5G provide you with the power to be a filmmaker in the palm of your hand without the need for extra equipment.
Your favourite Xbox games on Galaxy Note20 Series 5G: Beginning September 15, 2020, play over 100 Xbox games on your phone or tablet, directly from the cloud (beta) with Xbox Game Pass Ultimate6, including hits like Minecraft Dungeons and Gears 5. The Galaxy Note20 Series 5G gaming experience is further enhanced with its AI game booster and Bluetooth audio response optimization, and 240Hz touch latency on the Galaxy Note20 Ultra 5G. With hyper-fast 5G7 and Wi-Fi 68, get optimized gaming latency in every level and battle. A large and immersive display provides a smooth gaming experience thanks to the fastest Note processor yet9. Galaxy Note20 Series 5G is a pro-gaming set-up that fits in your pocket.
Cinematic Filmmaking in the Palm of Your Hand: With 21:9 aspect ratio and 24fps recording, the 8K camera on the Galaxy Note20 Series 5G now gives you ultra-high resolution and a professional quality video experience. Use powerful Pro Video mode with pro-grade focus, audio, exposure, lighting, zoom speed control, and 120fps shooting at FHD options for cinematic-style videos. Pro lenses and advanced Space Zoom10 allow you to photograph scenes in gorgeous detail. You can also control audio sources on the Galaxy Note20 Series 5G, adjusting and selecting between onboard mics or external sources, so the sound you want comes through clearly. Paired with Galaxy Buds Live, for example, you can record crystal-clear audio even with some noise in the background11.
Master Multitasking with Advanced Samsung DeX: For the first time with Samsung DeX12, wirelessly connect your Galaxy Note20 5G or Note20 Ultra 5G to a compatible Smart TV when you need a bigger screen. Manage two screens simultaneously, so you can text with your friends while watching a video on a compatible Smart TV.
Galaxy Legacy of Power and Performance The Galaxy Note has cemented its status as a power phone. The Galaxy Note20 Series 5G continues that legacy as the most powerful Note series yet13 to give you the things you know, love, and expect from Galaxy.
Galaxy Note20 Series 5G is built with the fastest processor of all our Galaxy smartphones. It features cutting-edge technology and a superb mobile experiences, without sacrificing the iconic design. Both Galaxy Note20 5G and Note20 Ultra 5G introduce new Mystic colours – soft neutral tones with a brand new, textured haze effect.
For the first time in the Note series, the Galaxy Note20 Ultra 5G offers the vivid and bright Dynamic AMOLED 2X display and 120Hz refresh rate14. These features combine to deliver buttery smooth visuals on our best Note display yet, which automatically adjusts to the content you are viewing to extend your battery life. Sporting an all-day intelligent battery15and Super Fast Charging capabilities, get hours of power from minutes of charge16 so you worry less about running out of power.
Samsung 5G leadership delivers next-level power for everything you love to do thanks to hyper-fast 5G17. Galaxy Note20 Series 5G automatically searches and recommends high speed networks and can access Wi-Fi 618 networks with optimized latency for various streaming services. You can be confident your Galaxy Note20 Series 5G hardware and software is better protected end-to-end thanks to the Samsung Knox mobile security platform.
For the first time on a Note device, Ultra-Wideband (UWB) technology delivers an intuitive experience that makes sharing photos and videos with loved ones simple and quick. This advanced directional and spatial awareness technology allows you to simply point your Galaxy Note20 Ultra 5G to another UWB-enabled Galaxy device19, and the Nearby Share feature will automatically identify the people you're facing at the top of your sharing panel.
Unlock New Experiences with the Connected Galaxy Ecosystem Samsung Galaxy products and services are designed to work together effortlessly, helping elevate not only your work and play, but the things that are important to you. Take your Galaxy Note20 Series 5G to the next level by pairing it with other new additions to the Samsung Galaxy: Galaxy Tab S7 and Tab S7+, Galaxy Watch3, and Galaxy Buds Live. With these cutting-edge complements to the Note experience, you can enjoy a seamless ecosystem that helps to you work smarter, play longer, focus on wellness, and communicate with your loved ones.
Galaxy Tab S7 and Tab S7+, Versatile Tablets for Productivity and Creativity Galaxy Tab S7 and Tab S7+ are two versatile tablets that combine the power of a PC and the mobility of a tablet to help users get creative and stay productive. With the latest Galaxy Tab S processor20 and expandable memory up to 512GB21 , both tablets come with a 120Hz refresh rate and have an 11-inch and 12.4-inch display, respectively22.
The Galaxy Tab S7 and Tab S7+ come with a refined S Pen23 and Samsung Notes. Plus, transform your tablet with an optional, redesigned keyboard attachment24 to provide a PC-like experience — helping you get more done in less time. The S Pen is also your ideal creative companion for using excellent drawing and note taking apps such as Clip Studio Paint, Canva and Noteshelf25.
Galaxy Watch3 Galaxy Watch3 is the next-generation companion for managing your routines and smashing your fitness goals. Crafted with premium materials including stainless steel and genuine leather, and featuring a slimmed-down26 version of the popular rotating bezel, Galaxy Watch3 features the craftsmanship of a luxury timepiece while still being comfortable enough to wear around the clock.
This smartwatch isn't just appealing to the eye—it can help center your wellness experience27, sporting the most expansive wellness suite from Samsung yet. Paired with advanced sensor technology, Galaxy Watch3 offers total lifestyle management with an integrated heart rate sensor so you can make informed decisions about your fitness and wellness, and visibly track your improvement28. If you take a hard fall outdoors or in your home, the Fall Detection29 feature enables you to send a SOS message to emergency contacts for added peace of mind. For those who want to stay fit while being at home, Samsung Health provides more than 120 different home training programs so you can track your workout progress on your watch.
Galaxy Buds Live Meet the newest shape of our wireless earbuds – Galaxy Buds Live. With a truly iconic design and comfortable fit, they make a bold fashion statement that projects your unique style. Combining AKG's sound expertise with a 12mm speaker and bass duct that is our biggest ever speaker on Galaxy Buds yet, audio sounds deep and rich so you can enjoy music the way the artist intended. Galaxy Buds Live come with three microphones plus the Voice Pickup Unit that senses when your jaw is moving, and converts this data into voice signals to deliver enhanced sound quality. So you can feel like you're in the boardroom with your colleagues, even when you're working from home. These earbuds also feature Active Noise Cancellation30, pairing both live and spacious sound quality with the ability to tune in (or out) of the world around you.
Reshape What's Possible with Galaxy Z Fold2 Samsung continues to pioneer this novel category of mobile devices by introducing the next generation of foldables— Galaxy Z Fold2. After releasing two foldable devices and listening to user feedback on the most requested upgrades and new features, Samsung unveils the Galaxy Z Fold2 with meaningful innovations that offer users an enhanced refinement of the foldable experience31. Galaxy Z Fold2 combines the portability and flexibility of a smartphone with the power and screen size of a tablet for powerful productivity. Whether folded or unfolded, you can enjoy a luxury mobile experience with the premium design of Galaxy Z Fold2. The Galaxy Z Fold2 comes packed with two edge-to-edge, nearly bezel-less Infinity-O Displays. The Cover Screen is 6.2-inches32 and the large Main Screen is 7.6-inches33, making them both larger than the previous Galaxy Fold. With its sleek design and refined engineering, Galaxy Z Fold2 comes in two equally stunning colours: Mystic Black and Mystic Bronze. Samsung is building on its longstanding partnerships with Google and Microsoft to design a superb foldable experience. With Galaxy Z Fold2, Samsung will continue to inspire new possibilities for the foldable category.
Pre-Order and Early Purchase Offers Samsung is excited to be bringing our latest innovations to Canadian consumers in 2020. Canadians who pre-order the Galaxy Note20 Series 5G on Samsung.com/ca between August 5 and August 20, 2020 and complete their purchase will receive their choice of: (i) a Xbox Game Pass Bundle; or (ii) Galaxy Buds Live with purchase of Galaxy Note20 Ultra 5G, or Galaxy Buds+ with purchase of Galaxy Note20 5G34.
Canadians who purchase either Galaxy Buds Live35 or Galaxy Watch336 on Samsung.com/ca between August 5 and September 4, 2020 will receive a Wireless Charger Pad or Wireless Duo Pad, respectively.
At Samsung Experience Stores and all other partner locations, be among the first 15,000 Canadian customers to own the Galaxy Note20 Series 5G between August 5 and September 4, 2020 to receive an e-voucher redeemable online at Samsung.com/ca for your choice of: (i) a Xbox Game Pass Bundle; or (ii) Galaxy Buds Live with purchase of Galaxy Note20 Ultra 5G, or Galaxy Buds+ with purchase of Galaxy Note20 5G37.
At Samsung Experience Stores and all other partner locations, be among the first 3,300 Canadian customers to purchase Galaxy Buds Live38 between August 5 and September 4, 2020 to receive an e-voucher redeemable online at Samsung.com/ca for a Wireless Charger Pad.
At Samsung Experience Stores or at all other partner locations, be among the first 1,700 Canadian customers to purchase Galaxy Watch339 between August 5 and September 4, 2020 to receive an e-voucher redeemable online at Samsung.com/cafor a Wireless Duo Pad.
For customers looking to experience the latest Galaxy innovations in-store, please join us at one of our Samsung Experience Store locations across Canada, including the new Montreal Eaton Centre location opening today, August 5, 2020. Stores are located at:
CF Sherway Gardens
CF Toronto Eaton Centre
Metropolis at Metrotown
Montreal Eaton Centre
West Edmonton Mall
Yorkdale Shopping Centre
Availability
Galaxy Note20 5G and Galaxy Note20 Ultra 5G: Available for pre-order now at Samsung Experience Stores or through Samsung.com/ca, as well as across major Canadian carriers and retail partners, and available for purchase at retail as of August 21, 2020.
Galaxy Note20 5G will be available in Mystic Bronze, Mystic Grey and Mystic Green, with pricing starting at $1,399.99 (regular price).
Galaxy Note20 Ultra 5G will be available in Mystic Bronze and Mystic Black, starting at $1,819.99 (regular price) for the 128GB model and $2,029.99 (regular price) for the 512GB model (available in Mystic Black only).
Galaxy Tab S7 and Galaxy Tab S7+: Available in two variants - 128GB (Mystic Black, Mystic Silver, Mystic Bronze) and 256GB (Mystic Black) online at Samsung.com/ca and in-store at Samsung Experience Stores as well as major retailers across Canada starting on September 18, 2020. Galaxy Tab S7 pricing starts at $919.99 (regular price) for the 128GB model and $1,029.99 (regular price) for the 256GB model (Mystic Black only). Galaxy Tab S7+ pricing starts at $1,189.99 (regular price) for the 128GB model, and $1,299.99 (regular price) for the 256GB model (Mystic Black only).
Galaxy Watch3: Available in 45mm (Mystic Black, Mystic Silver) and 41mm (Mystic Bronze, Mystic Silver) online at Samsung.com/ca and in-store at Samsung Experience Stores as well as major retailers across Canada starting on August 5, 2020 for $549.99 (regular price) for the 41mm model and $599.99 (regular price) for the 45mm model.
Galaxy Buds Live: Available online at Samsung.com/ca starting August 5, 2020 in Mystic Bronze, Mystic White and Mystic Black for $249.99 (regular price) and in-stores at Samsung Experience Stores and major retailers across Canada starting August 21, 2020.
Galaxy Z Fold2: Will be available in Canada later this year – pricing and availability details to come.
*Infinity-O Display: a near bezel-less, full-frontal screen.*Measured diagonally, Galaxy Note20's screen size is 6.7" in the full rectangle and 6.6" with accounting for the rounded corners and Galaxy Note20 Ultra's screen size is 6.9" in the full rectangle and 6.8" with accounting for the rounded corners; actual viewable area is less due to the rounded corners and camera hole.*120Hz display only available on Galaxy Note20 Ultra.
Dimensions & Weight
[Device] 164.8 x 77.2 x 8.1mm, 208g
[Device] 161.6 x 75.2 x 8.3mm, 192g
[S Pen] 5.8 × 4.35 × 105.08mm, 3.04g
S Pen
Bluetooth enabled, Lithium Titanate Battery: Up to 24 hours of battery standby timePressure levels: 4096, Pen tip diameter: 0.7 mm, IP68
*S Pen's operable distance extends approximately 10 meters from the device in open space. Control range may vary depending on surroundings and other factors.*Using S Pen as a stylus does not require battery power. Actual battery life may vary depending on usage patterns and other factors.*IP68 rating is based on test conditions for submersion in up to 1.5 meters of freshwater for up to 30 minutes. Rinse residue/dry if wet.
*12MP Ultra Wide Camera. Pixel size: 1.4μm. FOV: 120˚. F.No (aperture): F2.2 *12MP Wide-angle Camera. Super Speed Dual Pixel AF, OIS. Pixel size: 1.8μm . FOV: 79˚. F.No (aperture): F1.8. 1/1.76" image sensor size *64MP Telephoto Camera. Pixel size: 0.8μm. FOV: 76˚. F.No (aperture): F2.0 Space Zoom . 3x Hybrid Optic Zoom . Up to 30x Super Resolution ZoomOIS (Optical Image Stabilization)Tracking AF
*Galaxy Note20's Hybrid Optic Zoom combines high-resolution image sensor and lens.*Super Resolution Zoom includes digital zoom, which may cause some image deterioration.
12GB RAM (LPDDR5) with 512GB internal storage12GB RAM (LPDDR5) with 128GB internal storage
8GB RAM (LPDDR5) with 128GB internal storage
* Actual storage available may vary depending on pre-installed software.
ExpandableMemory & SIM Card
Single SIM model: one Nano SIM and one MicroSD slot (up to 1TB)
*Expandable memory only available on Galaxy Note20 Ultra. MicroSD card sold separately.
Battery
4,500mAh (typical)
4,300mAh (typical)
*Typical value tested under third-party laboratory condition. Typical value is the estimated average value considering the deviation in battery capacity among the battery samples tested under IEC 61960 standard. Rated (minimum) capacity is 4170mAh for Galaxy Note20 and 4370mAh for Galaxy Note20 Ultra. Actual battery life may vary depending on network environment, usage patterns and other factors.
Charging
Improved wireless charging speeds with Fast Wireless Charging 2.0USB PD 3.0 (PPS) certified Fast Charging for wired charging (AFC and QC2.0 compatible)*WPC certified Wireless charging*Wireless PowerShare
Fast Wireless Charging 2.0 currently available with Wireless Charger Stand, Wireless Charger Duo Pad, and other devices that support 10W or more wireless charging. Sold separately. Actual charging speed may vary depending on the actual usage, charging conditions, and other factors. Wireless charger requires power connection. Recommend using in-box charging cable and/or travel adapter for use of third party items may cause damage to the Wireless Charger Stand and Wireless Charger Duo Pad or a decrease in charging speed. *Wireless PowerShare is limited to Samsung or other brand smartphones with Qi wireless charging, such as Galaxy Z Fold2, Galaxy Note20, Galaxy Note20 Ultra, Galaxy S20, S20+, S20 Ultra, Z Flip, Note10, Note10+, S10e, S10, S10+, Fold, S9, S9+, S8, S8+, S8 Active, S7, S7 edge, S7 Active, S6, S6 edge, S6 Active, S6 edge+, Note9, Note8, Note FE, Note5, and wearables such as Galaxy Buds Live, Galaxy Watch3, Galaxy Watch Active2, Galaxy Watch Active, Gear Sport, Gear S3, Galaxy Watch, and Galaxy Buds. If battery power is lower than 30% Wireless PowerShare may not function. May not work with certain accessories, covers, other brand devices, or some Samsung wearables. May affect call reception or data services, depending on your network environment.
OS
Android 10
Network
[5G] 5G Non-Standalone (NSA), Standalone (SA), Sub6[LTE] Enhanced 4x4 MIMO, Up to 7CA, LTE Cat.20, Up to 2.0Gbps Download / Up to 200Mbps Upload[Wi-Fi] Wi-Fi 802.11 a/b/g/n/ac/ax 2.4G+5GHz, HE80, MIMO, 1024-QAM, Up to 1.2Gbps Download / Up to 1.2Gbps Upload[Bluetooth] Bluetooth® v 5.0, USB type-C, NFC, Location (GPS, Galileo, Glonass, BeiDou)[Ultra Wide Band]
*Actual speed may vary depending on market, carrier, and user environment.*Requires optimal 5G connection. Actual speed may vary depending on market, carrier, and user environment.*Galileo and BeiDou coverage may be limited. BeiDou may not be available for certain markets.*Ultra Wide Band supported on Galaxy Note20 Ultra.
Lock type: pattern, PIN, passwordBiometric lock type: Fingerprint, Face recognition
Audio
[Stereo Speakers by AKG]Surround sound with Dolby Atmos technology (Dolby Digital, Dolby Digital Plus included.) [Ultra high quality audio playback]UHQ 32-bit &DSD64/128 supportPCM: Up to 32 bits, DSD: DSD64/128*DSD64 and DSD128 playback can be limited depending on the file format. [Audio playback format]MP3, M4A, 3GA, AAC, OGG, OGA, WAV, WMA, AMR, AWB, FLAC, MID, MIDI, XMF, MXMF, IMY, RTTTL, RTX, OTA, APE, DSF, DFF [Bluetooth]Dual Audio: connect two Bluetooth devices to the Galaxy Note20 or Note20 Ultra to play audio through the two devices simultaneously.*The two connected devices may exhibit a slight difference in sound output. Scalable Codec: Enhanced Bluetooth connection under ambient radio frequency interference.*Available only for certain accessories made by Samsung. [Recording]Recording quality is improved with the High AOP Mic that minimizes distortion in noisy environments.*AOP: Acoustic Overload Point
Video
[Video playback format]MP4, M4V, 3GP, 3G2, WMV, ASF, AVI, FLV, MKV, WEBM [TV connection]Wireless: Smart View (screen mirroring 1080p at 30 fps)Wired: supports DisplayPort over USB type-C. Supports video out when connecting via HDMI Adapter. (DisplayPort 4K UHD at 60 fps)
Water Resistance
IP68
*IP68 is based on test conditions for submersion in up to 1.5 meters of freshwater for up to 30 minutes. Rinse residue/dry if wet. Not advised for beach or pool use.
* Specs subject to change without notice. Specs vary by markets/carriers.
* All functionality, features, specifications and other product information provided in this document including, but not limited to, the benefits, design, pricing, components, performance, availability, and capabilities of the product are subject to change without notice.
About Samsung Electronics Canada Inc. Samsung Electronics Canada inspires Canadians to reach their full potential through a transformative ecosystem of products and services that deliver innovation and distinct design to every aspect of their connected lives. The company is redefining the worlds of TVs, smartphones, virtual reality and wearable devices, tablets and digital appliances. In 2020, Samsung was ranked as one of Canada's "Most Reputable Companies" in Leger's Corporate Reputation Study. Dedicated to helping make a difference in the lives of Canadians, Samsung's award-winning corporate giving initiatives support public education and health-related issues in communities across the country. To discover more, please visit www.samsung.com/ca.
1 Compared to Galaxy Fold
2 Compared to Galaxy Note10
3 Galaxy Note20 5G has 40% latency improvement over Note10;Galaxy Note20 Ultra has 80% latency improvement (down to 9ms) over Note10.
4 Link to Windows requires the Your Phone app (free download), a Microsoft account and Windows 10. Some mobile apps may have security features that prevent the mobile app from being viewed on PC.
5 Service will be available starting later this year. Need to be signed into the same Microsoft account. Microsoft Outlook sync for web version only
6 Service available in Canada later this year. Controller may be needed to play some games from Xbox Game Pass Ultimate. Controller sold separately. Paid subscription to Xbox Game Pass Ultimate required. Game streaming (beta) available from September 15, 2020; requires Xbox Game Pass Ultimate, sufficient network speed, and supported controller (each sold separately). Streaming limits apply. Catalog varies over time and by market. Actual speed may vary depending on market, carrier, and user environment.
7 Requires optimal 5G network connection, available in select markets. Check with your carrier for availability and details. Download and streaming speeds may vary based on content provider, server connection and other factors.
8 Faster than previous Wi-Fi protocols. Only available where Wi-Fi 6 is supported. Availability of Wi-Fi 6 support may vary depending on country or region.
9 Compared to Galaxy Note10.
10 Space Zoom includes digital zoom, which may cause some image deterioration.
11 Compatible with Bluetooth or USB-C accessories, sold separately.
12 Samsung DeX wireless connection requires smart TV with Miracast support; both devices must be on same Wi-Fi network. Samsung DeX provides optimized experience with Samsung smart TV launched after 2019
13 Compared to Galaxy Note10.
14 Default screen refresh rate is 60Hz. Requires screen setting at 120Hz screen refresh rate.
15 Based on average battery life under typical usage conditions. Average expected performance based on typical use. Actual battery life depends on factors such as network, features selected, frequency of calls and voice, data, and other application usage patterns. Results may vary.
16 When using the included charger and cable.
17 Requires optimal 5G network connection, available in select markets. Check with your carrier for availability and details. Download and streaming speeds may vary based on content provider, server connection and other factors.
18 Faster than previous Wi-Fi protocols. Only available where Wi-Fi 6 is supported. Availability of Wi-Fi 6 support may vary depending on country or region.
19 Point to Share works between Samsung devices that support UWB.
20 Thirty percent faster compared to Galaxy Tab S6
21 MicroSD sold separately
22 Galaxy Tab S7 11" screen is a LTPS TFT LCD screen. Galaxy Tab S7+ 12.4" screen is a sAMOLEDTM screen. Measured diagonally as a full rectangle without accounting for the rounded corners. Actual viewable area is less due to the rounded corners.
23 Compared to Galaxy Tab S6 S Pen.
24 Keyboard accessory sold separately.
25 Canva and Noteshelf are proloaded in Tab S7｜S7+ as a stub. Clip Studio Paint is preloaded in S7｜S7+ however the preload may not be supported in some regions. Clip Studio Paint is available in the Galaxy Store.
26 14% thinner, 8% smaller and 15% lighter than the original Galaxy Watch3
27 Intended for general wellness and fitness purposes only.
28 Intended for general wellness and fitness purposes only. Heart rate tracking function on the watch can be used as standalone, but data stored in the watch may only be partially displayed after a certain period of time. Smartphone pairing is recommended in order to keep all data stored.
29 This feature is intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.
30 Features including Active Noise Cancellation are enabled through a Bluetooth connection or the Galaxy Wearable app on Android, available through the Galaxy Store or Google Play Store, and the Galaxy Buds app on iOS devices, available through the App Store.
31 As compared to Galaxy Fold.
32 Measured diagonally, the screen size is 6.2" in a full rectangle and 6.2" accounting for the rounded corners. The actual viewable area is smaller due to the rounded corners and camera hole.
33 Measured diagonally, the screen size is 7.6" in a full rectangle and 7.6" accounting for the rounded corners. The actual viewable area is smaller due to the rounded corners and camera hole.
34 Terms and conditions apply. Pre-order a Galaxy Note20 5G or Galaxy Note20 Ultra 5G on www.samsung.com/ca from August 5th – August 20th, 2020 and receive a bonus gift upon completion of your device purchase as shown above (customers' choice). While quantities last. No rain checks. Limit of one bonus per device purchase. Open to Canadian Residents only. For full details, visit www.samsung.com/ca/promotions.
35 Terms and conditions apply. Purchase Galaxy Buds Live from August 5th – September 4th 2020 on samsung.com/ca and receive and receive a bonus Wireless Charger Pad. While quantities last. No rain checks. Limit of one bonus per device purchase. Open to Canadian Residents only. For full details, visit www.samsung.com/ca/promotions.
36 Terms and conditions apply. Purchase a Galaxy Watch3 from August 5th – September 4th 2020 samsung.com/ca and a bonus Wireless DuoPad. While quantities last. No rain checks. Limit of one bonus per device purchase. Open to Canadian Residents only. For full details, visit www.samsung.com/ca/promotions.
37 Terms and conditions apply. Be among the first 15,000 customers to either (i) pre-order from August 5th – August 20th, 2020, or (ii) purchase from August 2st – September 4th, 2020 a Galaxy Note20 5G or a Galaxy Note20 Ultra 5G and receive an E-Voucher upon completion of your purchase (redeemable on Samsung.com/ca Aug18 – Sept 30, 2020 for one of either a Microsoft Game Pass Bundle or Samsung Buds+ (for purchase of Galaxy Note205G) OR one of either a Microsoft Game Pass Bundle or Galaxy Buds Live (for purchase of Galaxy Note20 Ultra 5G). E-Vouchers can be downloaded from the Samsung Members app on your Galaxy Note20 5G or Galaxy Note20 Ultra 5G in the Benefits Section between Aug 18 – Sept 30, 2020. Visit Samsung.com/evoucher for full details.
38 Terms and conditions apply. Purchase Galaxy Buds Live from August 5th – September 4th 2020 and receive an E-Voucher redeemable on samsung.com/ca between August 18th and September 30th 2020 for a bonus Wireless Charger Pad. While quantities last. No rain checks. Limit of one bonus per device purchase. Open to Canadian Residents only. For full details, visit www.samsung.com/ca/promotions.
39 Terms and conditions apply. Purchase a Galaxy Watch3 from August 5th – September 4th 2020 and receive an E-Voucher redeemable on samsung.com.ca between August 18th and September 30th, 2020 for a bonus Wireless DuoPad. While quantities last. No rain checks. Limit of one bonus per device purchase. Open to Canadian Residents only. For full details, visit www.samsung.com/ca/promotions.
SOURCE Samsung Electronics Canada Inc.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
